BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31103260)

  • 1. The N-terminal sequence of murine PRMT5 variant 2 is required for Hsp70 interaction and CHIP ligase-mediated degradation.
    Lu W; Kim JD; Tabara S; Kwon C; Mizukami H; Kimura K; Fukamizu A
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1185-1191. PubMed ID: 31103260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
    Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD
    Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone H2A and H4 N-terminal tails are positioned by the MEP50 WD repeat protein for efficient methylation by the PRMT5 arginine methyltransferase.
    Burgos ES; Wilczek C; Onikubo T; Bonanno JB; Jansong J; Reimer U; Shechter D
    J Biol Chem; 2015 Apr; 290(15):9674-89. PubMed ID: 25713080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.
    Wang M; Fuhrmann J; Thompson PR
    Biochemistry; 2014 Dec; 53(50):7884-92. PubMed ID: 25485739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours.
    Yuan HF; Zhao M; Zhao LN; Yun HL; Yang G; Geng Y; Wang YF; Zheng W; Yuan Y; Song TQ; Niu JQ; Zhang XD
    Acta Pharmacol Sin; 2022 Sep; 43(9):2373-2385. PubMed ID: 35046516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OGG1 regulates the level of symmetric dimethylation of histone H4 arginine-3 by interacting with PRMT5.
    Zhou X; Wang W; Du C; Yan F; Yang S; He K; Wang H; Zhao A
    Mol Cell Probes; 2018 Apr; 38():19-24. PubMed ID: 29409673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel PRMT5-mediated arginine methylations of HSP90A are essential for maintenance of HSP90A function in NDRG2
    Ichikawa T; Shanab O; Nakahata S; Shimosaki S; Manachai N; Ono M; Iha H; Shimoda K; Morishita K
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118615. PubMed ID: 31765670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEP50/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH/NUMB complex.
    Abe Y; Suzuki Y; Kawamura K; Tanaka N
    Commun Biol; 2019; 2():23. PubMed ID: 30675521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
    Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B
    Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P42 Ebp1 regulates the proteasomal degradation of the p85 regulatory subunit of PI3K by recruiting a chaperone-E3 ligase complex HSP70/CHIP.
    Ko HR; Kim CK; Lee SB; Song J; Lee KH; Kim KK; Park KW; Cho SW; Ahn JY
    Cell Death Dis; 2014 Mar; 5(3):e1131. PubMed ID: 24651434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and interactions of the helical and U-box domains of CHIP, the C terminus of HSP70 interacting protein.
    Xu Z; Devlin KI; Ford MG; Nix JC; Qin J; Misra S
    Biochemistry; 2006 Apr; 45(15):4749-59. PubMed ID: 16605243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.
    Saha K; Adhikary G; Eckert RL
    J Invest Dermatol; 2016 Jan; 136(1):214-224. PubMed ID: 26763441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins.
    Branscombe TL; Frankel A; Lee JH; Cook JR; Yang Z; Pestka S; Clarke S
    J Biol Chem; 2001 Aug; 276(35):32971-6. PubMed ID: 11413150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.
    Stopa N; Krebs JE; Shechter D
    Cell Mol Life Sci; 2015 Jun; 72(11):2041-59. PubMed ID: 25662273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKM2 compensates for proteasome dysfunction by mediating the formation of the CHIP-HSP70-BAG3 complex and the aggregation of ubiquitinated proteins.
    Zhang C; Tang Q; Xia H; Xu H; Bi F
    FASEB J; 2022 Jan; 36(1):e22121. PubMed ID: 34951719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
    Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
    Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
    Chen H; Lorton B; Gupta V; Shechter D
    Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin.
    Cai S; Wang P; Xie T; Li Z; Li J; Lan R; Ding Y; Lu J; Ye J; Wang J; Li Z; Liu P
    Pharmacol Res; 2020 Nov; 161():105104. PubMed ID: 32739429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHIP functions an E3 ubiquitin ligase of Runx1.
    Shang Y; Zhao X; Xu X; Xin H; Li X; Zhai Y; He D; Jia B; Chen W; Chang Z
    Biochem Biophys Res Commun; 2009 Aug; 386(1):242-6. PubMed ID: 19524548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation.
    Yi M; Ma Y; Chen Y; Liu C; Wang Q; Deng H
    Mol Cell Proteomics; 2020 Nov; 19(11):1910-1920. PubMed ID: 32868396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.